AIDS VACCINE ADVOCACY COALITION
423 west 127th street 4th fl, NEW YORK, NY 10027 www.avac.org

Total Revenue
$12,108,505
Total Expenses
$15,366,260
Net Assets
$7,352,570

Organizations Filed Purposes: THE PURPOSES OF THE ORGANIZATION SHALL BE TO: INCREASE PUBLIC AWARENESS OF AND COMMUNITY PARTICIPATION IN THE EFFORTS TO ADVANCE THE NEED FOR A WELL-FUNDED, COORDINATED HIV PREVENTION RESEARCH PROGRAM; IDENTIFY AND MITIGATE OR ELIMINATE BARRIERS TO THE DEVELOPMENT OF AND ACCESS TO NEW HIV VACCINES AND OTHER PREVENTION OPTIONS; AND PROMOTE INCREASED RESOURCES FOR HIV VACCINE AND PREVENTION RESEARCH BY GOVERNMENT AGENCIES.

PRODUCT INTRODUCTION AND ACCESS: THE PRODUCT INTRODUCTION PROGRAM IS DESIGNED TO IDENTIFY AND ANTICIPATE NEEDS AND GAPS AND PROVIDE TARGETED TOOLS, SUPPORT AND PLATFORMS TO EXPAND ACCESS TO HIV/AIDS PREVENTION. THE PROGRAM FOCUSES ON: SUCCESSFUL SCALE-UP AND INTRODUCTION IN THREE PRIORITY COUNTRIES FROM THE OUTSET; DEVELOP ADAPTABLE AND SCALABLE TOOLS TO SUPPORT OTHER COUNTRIES; SUPPORT THE DEVELOPMENT OF MARKETABLE PRODUCTS IN THE HIV PREVENTION RESEARCH PIPELINE; AND CREATE A FLEXIBLE MECHANISM TO ASSIST PRODUCT DEVELOPERS, FUNDERS AND COUNTRY PROGRAMS TO IDENTIFY AND ADDRESS BARRIERS TO IMPROVED PRODUCTS AND ACCELERATED INTRODUCTION. THE PROJECT IS IMPLEMENTED IN COLLABORATION WITH ONE PRIMARY SUBGRANTEE THE CLINTON HEALTH ACCESS INITIATIVE (CHAI), FINAL MILE WHO FOCUSES ON END USER RESEARCH AND POPULATION SERVICES INTERNATIONAL (PSI) THAT SUPPORTS END USER RESEARCH IN SOUTH AFRICA.

RESEARCH ENGAGEMENT AND PREPAREDNESS: RESEARCH PREPAREDNESS IS DESIGNED TO SHAPE THE R&D ENVIRONMENT THROUGH ADVOCACY FOR INVESTMENT, POLITICAL SUPPORT, AND Good Participatory Practice. AVAC DEVELOPED MATERIALS AND DOCUMENTS RELATING TO THE PREVENTION OF HIV/AIDS; CONVENED MULTIPLE MEETINGS WITH STAKEHOLDERS SUCH AS RESEARCHERS AND CIVIL SOCIETY LEADERS TO DISCUSS RESEARCH FINDINGS AND ISSUED SUBGRANTS TO 8 PARTNERS IN THE US AND AFRICA UNDER THE HIV BIOMEDIAL PREVENTION RESEARCH PROJECT FUNDED BY USAID: NEW HIV MICROBICIDES ADVOCACY SOCIETY (NHVMAS) IN NIGERIA, AVENIR HEALTH, FHI 360, INTERNATIONAL AIDS VACCINE INITIATIVE (IAVI) AND INTERNEWS IN THE US, HIV/AIDS VACCINE ETHICS GROUP OF THE UNIVERSITY OF KWAZULU - NATAL (HAVEG), WITS REPRODUCTIVE HEALTH AND HIV PREVENTION (WITS) AND WACI HEALTH IN SOUTH AFRICA. AVAC ALSO ISSUED SUBGRANTS TO CLI, TNCA, MESHA, CCI, PAKACHERE, HEALTH GAP, ICW-EA, HEJNU, ZAMCOM, ZAN. IT ALSO INCLUDES $2,500 IN DISCRETIONARY FUNDS TO FELLOWS AND RX ROAR MEMBERS.

IMPLEMENTATION ADVOCACY: THE IMPLEMENTATION ADVOCACY PROGRAM WHERE AVAC PROVIDES TECHNICAL SUPPORT IS DESIGNED TO IMPROVE EVIDENCE-BASED AND RIGHTS-BASED DONOR AND GOVERNMENT INVESTMENTS IN A COMPREHENSIVE RESPONSE TO THE HIV/AIDS EPIDEMIC.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Mitchell WarrenEXECUTIVE DIRECTOR50$354,268
Jessica RodriguesDIRECTOR:PRODUCT INTRODUCTION40$193,707
Kevin FisherDIRECTOR:POLICY, DATA & ANALY40$190,499
Stacey HannahDIRECTOR: RESEARCH ENGAGEMENT40$161,730
Manju ChataniDIRECTOR:PARTNERSHIPS & CAPACI40$161,015
Erin KiernonCHIEF OPERATING OFFICER40$158,988
Wanda BucknerSENIOR FINANCE MANAGER40$155,715
Abigail SmithCHIEF FINANCIAL OFFICER40$18,750
Blair HanewallBOARD MEMBER1$0
Susie MccleanBOARD MEMBER1$0
Vuyiseka DubulaBOARD MEMBER1$0
Steve WakefieldBOARD MEMBER1$0
Sarah SchlesingerBOARD MEMBER1$0
Helen ReesBOARD MEMBER1$0
Alexandre MenezesBOARD MEMBER1$0
Catherine Hankinsboard Member1$0
Lucy Ghatiboard Member1$0
Anne-Marie DuliegeBOARD MEMBER1$0
David Cookboard member1$0
Dr Elizabeth Anne BukBOARD MEMBER1$0
Jintanat AnanworanichBoard Member1$0
Craig McclureSecretary1$0
Maureen BaehrTreasurer & Vice President1$0
Todd SummersPresident1$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202033189349300538_public.xml